MedTrace Logo

Evaluation of High Dose Methotrexate Toxicity

NCT06123403 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2023-11-08

No results posted yet for this study

Summary

This study aims to:

1. Evaluation of high dose methotrexate related toxicities among children admitted to Sohag Oncology Centre.
2. Role of methotrexate blood level in prediction of high dose methotrexate related toxicities.
3. Role of Cystatin C as a predictor for acute kidney injury in high dose methotrexate related toxicities.
4. Factors affecting outcome of high dose methotrexate related toxicities.

Conditions

  • Methotrexate Toxicity

Interventions

DIAGNOSTIC_TEST

blood methotrexate level and Cystatin C level

blood methotrexate level and Cystatin C level

Sponsors & Collaborators

  • Sohag University

    lead OTHER

Principal Investigators

  • Maha A Helal, Professor · Sohag University

Eligibility

Min Age
1 Year
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-31
Primary Completion
2025-01-31
Completion
2025-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06123403 on ClinicalTrials.gov